Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TBO-309 by ThromBio Holdings for Acute Ischemic Stroke: Likelihood of Approval
TBO-309 is under clinical development by ThromBio Holdings and currently in Phase II for Acute Ischemic Stroke. According to GlobalData,...
TBO-309 by AstraZeneca for Acute Ischemic Stroke: Likelihood of Approval
TBO-309 is under clinical development by AstraZeneca and currently in Phase II for Acute Ischemic Stroke. According to GlobalData, Phase...
TBO-309 by Heart Research Institute for Acute Ischemic Stroke: Likelihood of Approval
TBO-309 is under clinical development by Heart Research Institute and currently in Phase II for Acute Ischemic Stroke. According to...